Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care System

Study acronym: CLEAR-HTN
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later across 2 updates Jul 31, 2026 → Nov 30, 2026
See other at-risk trials from AstraZeneca

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Sep 30, 2026 to Nov 30, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
    • Eligibility criteria expanded, about 4 words
  2. Primary and study completion pushed from Jul 31, 2026 to Sep 30, 2026v5
  3. 2 versions Re-verified since May 26, 2026, no change to tracked fieldsv3-v4
  4. Recruitment opened
    • Start date changed from estimate of Dec 31, 2025 to Mar 31, 2026
    • Study sites: 0 to 1
    • Study title shortened, about 3 words
    v2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AstraZeneca
734 trials monitored
See 61 trials at risk
Hypertension
1,945 trials monitored
See 101 trials at risk
This is a retrospective observational cohort study based on secondary use of routinely collected electronic health data. The design was selected to enable population-level characterisation of treatment patterns and clinical inertia (both diagnostic and therapeutic) in the management of hypertension across diverse settings in Brazil's public primary care system (SUS).
Trial Details
NCT Number NCT07361276
Lead Sponsor AstraZeneca
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 15,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov